UA100377C2 - Antibodies against il-25 - Google Patents
Antibodies against il-25Info
- Publication number
- UA100377C2 UA100377C2 UAA200911796A UAA200911796A UA100377C2 UA 100377 C2 UA100377 C2 UA 100377C2 UA A200911796 A UAA200911796 A UA A200911796A UA A200911796 A UAA200911796 A UA A200911796A UA 100377 C2 UA100377 C2 UA 100377C2
- Authority
- UA
- Ukraine
- Prior art keywords
- antibody
- treatment
- relates
- antibodies against
- asthma
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0707505.4A GB0707505D0 (en) | 2007-04-18 | 2007-04-18 | Antibodies against il-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA100377C2 true UA100377C2 (en) | 2012-12-25 |
Family
ID=38135020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200911796A UA100377C2 (en) | 2007-04-18 | 2008-04-17 | Antibodies against il-25 |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US8206717B2 (ru) |
| EP (1) | EP2144934B1 (ru) |
| JP (1) | JP5366930B2 (ru) |
| KR (1) | KR101605861B1 (ru) |
| CN (1) | CN101711256B (ru) |
| AU (1) | AU2008240436B2 (ru) |
| BR (1) | BRPI0810418A8 (ru) |
| CA (1) | CA2684492C (ru) |
| CO (1) | CO6260104A2 (ru) |
| CR (1) | CR11079A (ru) |
| CY (1) | CY1118244T1 (ru) |
| DK (1) | DK2144934T3 (ru) |
| EA (1) | EA018073B1 (ru) |
| EC (1) | ECSP099726A (ru) |
| ES (1) | ES2604255T3 (ru) |
| GB (1) | GB0707505D0 (ru) |
| GT (1) | GT200900271A (ru) |
| HN (1) | HN2009003038A (ru) |
| HR (1) | HRP20161548T1 (ru) |
| HU (1) | HUE030935T2 (ru) |
| IL (1) | IL201552A (ru) |
| LT (1) | LT2144934T (ru) |
| MX (1) | MX2009011234A (ru) |
| MY (1) | MY148451A (ru) |
| NI (1) | NI200900189A (ru) |
| NZ (1) | NZ581178A (ru) |
| PL (1) | PL2144934T3 (ru) |
| PT (1) | PT2144934T (ru) |
| RS (1) | RS55401B1 (ru) |
| SI (1) | SI2144934T1 (ru) |
| UA (1) | UA100377C2 (ru) |
| WO (1) | WO2008129263A1 (ru) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0817891D0 (en) | 2008-09-30 | 2008-11-05 | Medical Res Council | Antibodies against il-25 |
| US8574582B2 (en) * | 2008-10-31 | 2013-11-05 | Janssen Biotech, Inc. | Methods for mediating fibrotic response |
| GB0905972D0 (en) | 2009-04-06 | 2009-05-20 | Medical Res Council | Antibodies against IL-17BR |
| AU2010291985B2 (en) | 2009-09-14 | 2016-05-05 | The Regents Of The University Of Colorado | Modulation of yeast-based immunotherapy products and responses |
| JP5887337B2 (ja) * | 2010-03-30 | 2016-03-16 | ヤンセン バイオテツク，インコーポレーテツド | ヒト化ｉｌ−２５抗体 |
| US9546219B2 (en) | 2012-02-08 | 2017-01-17 | North Carolina State University | Treatment of allergic diseases with recombinant antibodies |
| JP6250351B2 (ja) * | 2013-09-30 | 2017-12-20 | シスメックス株式会社 | 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー |
| CN103792375B (zh) * | 2014-01-29 | 2017-07-07 | 华中科技大学同济医学院附属同济医院 | 外周血白细胞介素25水平在哮喘分型中的应用及分型方法 |
| EA036658B1 (ru) * | 2014-09-23 | 2020-12-04 | Регенерон Фармасьютикалз, Инк. | Антитела к il-25 и их применения |
| IL261802B2 (en) * | 2016-03-16 | 2024-01-01 | Abeome Corp | Neutralizing monoclonal antibodies to IL-25 and their use |
| WO2018017864A2 (en) * | 2016-07-20 | 2018-01-25 | Oncomed Pharmaceuticals, Inc. | Pvrig-binding agents and uses thereof |
| WO2018018082A1 (en) | 2016-07-26 | 2018-02-01 | The Australian National University | Immunostimulatory compositions and uses therefor |
| WO2018089335A1 (en) | 2016-11-09 | 2018-05-17 | North Carolina State University | Treatment of allergic diseases with chimeric protein |
| US12060437B2 (en) | 2018-03-23 | 2024-08-13 | North Carolina State University | Methods and compositions for antibody to high affinity receptor for IgE |
| US20210332123A1 (en) * | 2018-11-19 | 2021-10-28 | Suzhou Kanova Biopharmaceutical Co., Ltd. | Anti-il-25 antibodies and use thereof |
| GB202018015D0 (en) | 2020-11-16 | 2020-12-30 | Res & Innovation Uk | Composition and methods for the treatment of intestinal cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6569645B2 (en) | 1999-05-14 | 2003-05-27 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| CN1289668C (zh) * | 2003-06-12 | 2006-12-13 | 北京安波特基因工程技术有限公司 | 一种用于抗体改形的体外分子定向进化方法 |
| US8287851B2 (en) | 2005-03-08 | 2012-10-16 | Lorus Therapeutics Inc. | Use of interleukin 17E for the treatment of cancer |
| US20070237763A1 (en) | 2005-10-06 | 2007-10-11 | Baylor Research Institute | Compositions and methods for the treatment of cancer |
| GB0817891D0 (en) | 2008-09-30 | 2008-11-05 | Medical Res Council | Antibodies against il-25 |
-
2007
- 2007-04-18 GB GBGB0707505.4A patent/GB0707505D0/en not_active Ceased
-
2008
- 2008-04-17 MY MYPI20094358A patent/MY148451A/en unknown
- 2008-04-17 BR BRPI0810418A patent/BRPI0810418A8/pt not_active Application Discontinuation
- 2008-04-17 SI SI200831698A patent/SI2144934T1/sl unknown
- 2008-04-17 PT PT87370250T patent/PT2144934T/pt unknown
- 2008-04-17 RS RS20161009A patent/RS55401B1/sr unknown
- 2008-04-17 LT LTEP08737025.0T patent/LT2144934T/lt unknown
- 2008-04-17 HU HUE08737025A patent/HUE030935T2/en unknown
- 2008-04-17 EA EA200901421A patent/EA018073B1/ru not_active IP Right Cessation
- 2008-04-17 DK DK08737025.0T patent/DK2144934T3/en active
- 2008-04-17 JP JP2010503589A patent/JP5366930B2/ja not_active Expired - Fee Related
- 2008-04-17 KR KR1020097023939A patent/KR101605861B1/ko active IP Right Grant
- 2008-04-17 EP EP08737025.0A patent/EP2144934B1/en active Active
- 2008-04-17 MX MX2009011234A patent/MX2009011234A/es active IP Right Grant
- 2008-04-17 ES ES08737025.0T patent/ES2604255T3/es active Active
- 2008-04-17 UA UAA200911796A patent/UA100377C2/ru unknown
- 2008-04-17 PL PL08737025T patent/PL2144934T3/pl unknown
- 2008-04-17 AU AU2008240436A patent/AU2008240436B2/en not_active Ceased
- 2008-04-17 NZ NZ581178A patent/NZ581178A/en not_active IP Right Cessation
- 2008-04-17 CA CA2684492A patent/CA2684492C/en not_active Expired - Fee Related
- 2008-04-17 US US12/596,053 patent/US8206717B2/en active Active
- 2008-04-17 WO PCT/GB2008/001365 patent/WO2008129263A1/en active Application Filing
- 2008-04-17 CN CN2008800206204A patent/CN101711256B/zh not_active Expired - Fee Related
-
2009
- 2009-10-15 IL IL201552A patent/IL201552A/en active IP Right Grant
- 2009-10-16 HN HN2009003038A patent/HN2009003038A/es unknown
- 2009-10-16 GT GT200900271A patent/GT200900271A/es unknown
- 2009-10-16 NI NI200900189A patent/NI200900189A/es unknown
- 2009-10-28 CR CR11079A patent/CR11079A/es unknown
- 2009-11-03 CO CO09123670A patent/CO6260104A2/es active IP Right Grant
- 2009-11-10 EC EC2009009726A patent/ECSP099726A/es unknown
-
2016
- 2016-11-17 CY CY20161101187T patent/CY1118244T1/el unknown
- 2016-11-22 HR HRP20161548TT patent/HRP20161548T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA100377C2 (en) | Antibodies against il-25 | |
| UA116873C2 (uk) | Антитіло, яке зв'язується з ox40 | |
| UA113623C2 (uk) | Моноклональне антитіло проти інгібітору шляху тканинного фактора (tfpi) | |
| UA95068C2 (ru) | Антиген-связующая молекула, которая связывает egfr, вектор, который ее кодирует, и их применение | |
| UA115439C2 (uk) | Гуманізоване антитіло, яке розпізнає альфа-синуклеїн | |
| MX369148B (es) | Agentes de unión kir3dl2. | |
| MX2009012950A (es) | ANTICUERPOS HUMANIZADOS CONTRA EL GLOBULOMERO Aß (20-42) Y SUS USOS. | |
| UA114891C2 (uk) | ІЗОЛЬОВАНЕ АНТИТІЛО ЛЮДИНИ, ЯКЕ СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З АНГІОПОЕТИНПОДІБНИМ БІЛКОМ 3 ЛЮДИНИ (hАNGPTL3), ТА ЙОГО ЗАСТОСУВАННЯ | |
| UA115657C2 (uk) | Виділене антитіло, яке зв'язується з одним або декількома епітопами тау, фармацевтична композиція, що його містить, спосіб лікування та спосіб діагностики хвороби альцгеймера на основі виділеного антитіла | |
| WO2008079246A3 (en) | Cd44 antibodies | |
| UA115540C2 (uk) | Антитіло до il-36r | |
| EA201492101A1 (ru) | Антитела против fcrn | |
| MX2009003306A (es) | Anticuerpos humanos que se unen a cxcr4 y sus usos. | |
| WO2009112245A9 (en) | Antibody against the csf-1 r | |
| MX2010000537A (es) | Anticuerpos monoclonales contra glipicano-3. | |
| MX2009004532A (es) | Composiciones y metodos para unir esfingosina-1-fosfato. | |
| PH12015501505B1 (en) | Antibodies that bind to tl1a and their uses | |
| UA114902C2 (uk) | Виділене антитіло, яке зв'язує парний спіральний філамент-тау (псф-тау), та фармацевтична композиція, що містить таке антитіло | |
| WO2008134659A8 (en) | Antagonists to il-17a, il-17f, and il-23p19 and methods of use | |
| IL212633A (en) | A monoclonal antibody or its antigen-binding portion, its pharmaceutical preparations and its use in the preparation of cancer drugs | |
| MY150246A (en) | Alpha 5 - beta 1 antibodies and their uses | |
| CY1116313T1 (el) | Αντισωματα εναντιον il-25 | |
| CL2008003784A1 (es) | Anticuerpo humanizado anti proteina e2 del virus de la hepatitis c o un fragmento de union; acido nucleico que lo codifica; vector y celula huesped que comprenden dicho acido nucleico; metodo para producir el anticuerpo; composicion farmaceutica que comprende el anticuerpo | |
| EA201290849A1 (ru) | Оптимизированные моноклональные антитела против ингибитора пути тканевого фактора (tfpi) | |
| IN2012DN00797A (ru) |